US Companies Launch CRISPR Clinical Trial
Catherine Offord | Sep 3, 2018
The Germany-based study will test an ex vivo genome-editing therapy for the inherited blood disorder β-thalassemia.
More Cancer Mutations, Better Immunotherapy Outcomes
More Cancer Mutations, Better Immunotherapy Outcomes
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.
Resurrecting Smells
The Scientist Staff | Oct 31, 2016
Visit the Monell Chemical Senses Center in Philadelphia, where researchers are striving to find a cure for anosmia, the loss of a sense of smell.
Cognitive Neuroscience Lurking in Art
Kerry Grens | Oct 19, 2015
What can neuroscientists learn from the masters and other artists?